Britta Ney

PREVALENCE OF SEROUS TUBAL INTRAEPITHELIAL CARCINOMA (STIC) IN CLINICAL ROUTINE: A RETROSPECTIVE STUDY AT A UNIVERSITY HOSPITAL

Annika Rohner, Sabine Matovina, Luisa Tassa, Britta Ney et autres

de (code pays fourni par la source)

p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study

Martin Köbel, Eunyoung Kang, Ashley L. Weir, Peter Rambau et autres

Our objective was to test whether p53 expression status is associated with survival for women diagnosed with the most common ovarian carcinoma histotypes (high-grade serous carcinoma [HGSC], endometrioid carcinoma [EC], and clear cell carcinoma [CCC]) using a large multi-institutional cohort from the …

ca, au, Tanzanie, us, gb, de, br, pl, es, se, at, no (code pays fourni par la source)

Increased FOXJ1 protein expression is associated with improved overall survival in high-grade serous ovarian carcinoma: an Ovarian Tumor Tissue Analysis Consortium Study

Ashley L. Weir, Eunyoung Kang, Nicola S. Meagher, Gregg S Nelson et autres

BACKGROUND: Recently, we showed a >60% difference in 5-year survival for patients with tubo-ovarian high-grade serous carcinoma (HGSC) when stratified by a 101-gene mRNA expression prognostic signature. Given the varied patient outcomes, this study aimed to translate prognostic mRNA markers into protein …

au, ca, us, gb, at, de, br, pl, es (code pays fourni par la source)

576 Ovarian carcinoma precursor lesions in a walk-in series of opportunistic and prophylactic salpingectomies at the Tuebingen women’s hospital

Alfons B. Rohner, Britta Ney, Marcel Philip Grube, Hans C. Bösmüller et autres

de (code pays fourni par la source)

Das Expressionsmuster von CA-125 und Mesothelin in Primärtumor und Metastasen des high-grade serösen Ovarialkarzinoms. - Über den Einfluss dieser tumorassoziierten Antigene und tumor-infiltrierenden Lymphozyten auf die Prognose.

Britta Ney

Zielsetzung: Das Ovarialkarzinom ist der zweithäufigste gynäkologische Tumor mit der höchsten Letalitätsrate. Die epithelialen Karzinome machen fast 90% aller malignen Ovarialtumoren aus. Davon ist das high-grade seröse Ovarialkarzinom (HGSC), welches von dem low-grade serösen, dem endometrioiden, dem klarzelligen und muzinösen Karzinom unterschieden …

The immunopeptidomic landscape of ovarian carcinomas

Heiko J. Schuster, Janet K. Peper-Gabriel, Hans-Christian Bösmüller, Kevin Röhle et autres

Immunotherapies, particularly checkpoint inhibitors, have set off a revolution in cancer therapy by releasing the power of the immune system. However, only little is known about the antigens that are essentially presented on cancer cells, capable of exposing them to immune cells. …

de (code pays fourni par la source)